JPRN-C000000150已完成1 期
A Phase I/II Study of Amrubicine and Irinotecan in Patients with Advanced Small Cell Lung Cancer - A Phase I/II Study of Amrubicine and Irinotecan in Patients with Advanced Small Cell Lung Cancer
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •Presence of pulmonary fibrosis with symptoms or apparent abnormality on chest X-rays, 2) Acute inflammation, infection 3) Massive pleural effusion or pericardial effusion 4) Uncontrollable diabetes mellitus 5) ileus, intestinal paralysis, diarrhea 6) Symptomatic brain metastasis 7) Severe heart disease 8) Pregnancy 9) Severe drug allergies 10) Prior radiotherapy to the chest or the pelvis.
研究者
相似试验
已完成
1 期
Phase I/II Study of Irinotecan and Gemcitabine in Pediatric, adolescent and Young Adult Patients with Relapsed or Refractory Solid TumorsRelapse/refractory pediatric/AYA solid tumorJPRN-UMIN000020144Group for "combination chemotherapies for refractory Adolescent and Young Adult solid tumors "10
招募中
2 期
Phase II Study of Amrubicin and Nitroglycerin in Third-Line Chemotherapy in Previously Treated Patients with Non-Small-Cell Lung CancerPreviously treated non-small-cell lung cancerJPRN-UMIN000000813Division of Clinical Trial Design and Management, Translational Clinical Center, Kyoto University Hospital60
招募中
1 期
Phase I study of Amrubicin plus CISplatin and concurrent accelerated hyperfractionated thoracic radioTherapy for limited-disease small cell lung cancerJPRN-jRCT1071200033Taniguchi Hirokazu9
已完成
1 期
Phase I/II Trail of Gemcitabine and Irinotecan in Patients with Platinum Refractory and Resistant Ovarian cancer.Patients with platinum-refractory and &#8211resistant ovarian cancer ( including fallopian tube, primary peritoneal cancer)JPRN-UMIN000004449School of Medicine, Chiba University25
已完成
1 期
Phase 1-2 Study of Amrubicin plus Nedaplatin for Advanced Non-Small-Cell Lung Canceron-Small-Cell Lung CancerJPRN-UMIN000003282agasaki University Hospital35
